Tech Company Financing Transactions
Enara Bio Funding Round
On 10/3/2024, Enara Bio raised $32.5 million in Series B funding from M Ventures, Pfizer Venture Investments and RA Capital.
Transaction Overview
Company Name
Announced On
10/3/2024
Transaction Type
Venture Equity
Amount
$32,500,000
Round
Series B
Investors
M Ventures (Lead Investor)
Pfizer Venture Investments (Lead Investor)
Proceeds Purpose
The company intends to use the funds to advance its pipeline of TCR-based immunotherapies against novel and differentiated Dark Antigen targets for solid tumors.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
The Magdalen Centre, Oxford Science Park, 1 Robert Robinson
Oxford, OX4 4GA
UK
Oxford, OX4 4GA
UK
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Our name Enara Bio� is derived from an Arabic word meaning illumination, enlightenment and bringing light into the darkness. We are the leaders in exploring the hidden depths of cancer and T-cell biology to discover and characterize Dark Antigens�, a novel class of shared immunotherapy targets that arise from altered cellular processes in cancer cells. We believe that Dark Antigens have the core attributes that will enable cancer immunotherapies to improve treatment outcomes for broad patient populations.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kevin Pojasek
Chief Medical Officer
Sophie Papa
Chief Operating Officer
David Watson
Chief Scientific Officer
Joseph Dukes
VP - Bus. Development
Andrew Fadden
Browse more venture capital transactions:
Prev: 10/3/2024: Yung Sidekick venture capital transaction
Next: 10/3/2024: Paren venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on tech company VC transactions. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs